Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
fda
life sciences
national blog main
2
×
national top stories
san francisco blog main
san francisco top stories
arena pharmaceuticals
avapritinib
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
cancer
cardiovascular disease
colorectal cancer
cstone pharmaceuticals
deals
detroit blog main
detroit top stories
eisai
eli lilly
europe blog main
europe top stories
european medicines agency
fisogatinib
flatiron health
genentech
hepatocellular carcinoma
indiana blog main
indiana top stories
investing
jeff albers
lorcaserin
lung cancer
medullary thyroid cancer
national
What
cancer
drug
fda
2
×
marketing
2
×
approval
blueprint
candidate
currently
eisai
flags
higher
incidence
lorcaserin
loss
market
medicine
medicines
muscle
pact
patients
post
pulls
regulatory
ret
review
risks
roche
study
team
took
weight
wins
withdrawing
Language
unset
Current search:
marketing
×
fda
×
" national blog main "
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks